ArticlePigment cell & melanoma research2025

Combination of the Novel RAF Dimer Inhibitor Brimarafenib With the MEK Inhibitor Mirdametinib Is Effective Against NRAS Mutant Melanoma.

Flavia L Tellenbach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.